questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the supply of anti-viral drug Sotrovimab for immunocompromised patients.
answerText: The National Institute for Health and Care Excellence (NICE) recommends sotrovimab as an option for the treatment of patients with COVID-19 meeting specified clinical criteria and subject to a commercial arrangement agreed with the company. The National H...
heading: Sotrovimab